Aug 26 2009
More Evidence that Genetics Can Reduce the Efficacy of Anti-Clotting Medication Clopidogrel
A new report in the Journal of the American Medical Association adds to the mounting evidence that genetic variations impact the efficacy of clopidogrel (Plavix®), a drug used to prevent blood clots in people who have had a heart attack or stroke and also those with peripheral artery disease and unstable angina.
Previous research has shown [...]
